Why the study?
Patients with severe tricuspid regurgitation face significant morbidity and mortality, but data on long-term clinical outcomes and health care resource utilization remain limited.
Population
1190 patients with severe TR and no previous tricuspid valve surgery
Design
Retrospective database cohort study
Follow-up
3 years
Authors
Loading...
Severe TR linked to high long-term morbidity and costs; leaves open optimal management pending prospective trials.
Patients with severe tricuspid regurgitation face extremely high 3-year mortality (47.9%) and substantial healthcare costs, highlighting the significant clinical and economic burden of this condition.
Madhavan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: